Consultation on famoxadone and its associated end-use product, Proposed Re-evaluation Decision PRVD2026-02
Current status: Open
Opened on 31 March 2026 and will close for consultation on 29 June 2026.
Health Canada is consulting Canadians on the proposal to continue registration of famoxadone and its associated end-use product registered for sale and use in Canada, with proposed updates to standard label statements.
Famoxadone is a protectant and locally systemic fungicide used to control early and late blight in potato and tomato. It is also used to control caneberry spur blight, caneberry anthracnose, cane botrytis, and preharvest fruit rot in Crop subgroup 13-07A: Caneberries (blackberry, red and black raspberry, loganberry, cultivars and hybrids of these). Famoxadone belongs to the group of fungicides classified as quinone outside inhibitors (Group 11) that target complex III of fungal respiration (ubiquinol oxidase, quinone outside site). There is one technical and one commercial class product registered in Canada. The commercial end-use product is a dry flowable that is co-formulated with cymoxanil. It is applied as a foliar spray by ground application (field sprayer or air assist sprayer) and aerial application.
Registered products containing famoxadone can be found in the Pesticide Product Information Database and in Appendix I. Currently registered products containing famoxadone can be found in the Pesticide Product Information Database and in Appendix I of PRVD2026-02.
For more information on the proposed decision open the "summary of the Proposed Re-evaluation Decision".
How to get involved
This consultation is open for comment from 31 March 2026 to 29 June 2026 (90 calendar days).
To comment on PRVD2026-02:
- Step 1: Open the summary of the proposed re-evaluation decision to access the document.
- Step 2: Submit comments to the Pest Management Regulatory Agency Publications Section on or before 29 June 2026
Please be sure to include the title of the consultation document on which you are commenting.
Health Canada will consider all comments that are directly related to the proposed decision, received up to 90 days from the date of publication of this document (by 29 June 2026) before making a final decision on the proposed re-evaluation for famoxadone and its associated end-use products.
Reporting to the people of Canada
Health Canada will make the results of this consultation available on this website. Once the decision is finalized, the PMRA will post a Re-evaluation Decision on the Pesticides and Pest Management Reports and Publications portion of Canada.ca.
If you have any questions, contact the Pest Management Information Service.
Interested in our other consultations? Sign up and stay informed about topics that matter to you.